29+ min ago  (297+ words) In a breakthrough that could redefine crop biotechnology, scientists at the Indian Council of Agricultural Research's Central Rice Research Institute have developed and experimentally validated the world's first AI-designed genome-editing tool for plants, marking a major advance beyond the existing…...

4+ hour, 9+ min ago  (734+ words) Renaissance Bioscience has developed a novel yeast-derived "virus-like particle" (VLP) system which it claims could dramatically expand the scope of its RNA interference (RNAi) based platform, enabling the production of stable, cost-effective biopesticides capable of tackling a far broader range…...

7+ hour, 46+ min ago  (11+ words) The Greatest News Site On The Internet. Home of CFP Nation....

10+ hour, 50+ min ago  (442+ words) JAKARTA - Scientists at King Abdullah University of Science and Technology or KAUST have developed nanoparticles that can carry six proteins into living cells. Citing an Arab News report, Friday, May 15, the proteins then work together like a mini "drug factory…...

7+ hour, 33+ min ago  (43+ words) Seeking Alpha The following slide deck was published by Tenaya Therapeutics, Inc. in conjunction with this event....

2+ hour, 48+ min ago  (793+ words) Last month, the FDA approved Regeneron Pharmaceuticals" Otarmeni for a specific type of hearing loss, validating the concept of genetic medicines. As these medicines continue to advance, countless more conditions stand to benefit from the approach. Researchers are taking note....

8+ hour, 2+ min ago  (417+ words) Duracyte's implants employ cells engineered to produce therapeutic protein, bypassing the complexities of traditional biologics manufacturing. The startup's marriage of biotechnology with electronics comes with on-board sensors that enable clinicians to monitor and control an implant's drug production process. Biotechnology…...

23+ hour, 53+ min ago  (13+ words) stat. gov. pl...

1+ day, 1+ hour ago  (219+ words) Published May 17, 2026 6: 00 AM EDT Gene therapy " attempting to help a patient by modifying a gene expression in their body, basically " has shown immense promise for treating a growing range of severe illnesses and disabilities, from Huntington's Disease to congenital deafness....

1+ day, 4+ hour ago  (782+ words) 4 D Molecular Therapeutics (NASDAQ: FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4 D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial…...